FLSM
Frazier Life Sciences Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8M | Buy |
983,715
+325,000
| +49% | +$11.8M | 1.43% | 17 |
|
|
2025
Q1 | $23.9M | Hold |
658,715
| – | – | 1.09% | 20 |
|
|
2024
Q4 | $27.7M | Buy |
658,715
+25,000
| +4% | +$1.05M | 1.15% | 21 |
|
|
2024
Q3 | $35.2M | Buy |
633,715
+208,715
| +49% | +$11.6M | 1.41% | 21 |
|
|
2024
Q2 | $17.5M | Buy |
+425,000
| New | +$17.5M | 0.82% | 28 |
|